Return On Assets of KalVista Pharmaceuticals, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
KalVista Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • KalVista Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -75%, a 12% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Return On Assets for 2024 was -113%, a 63% decline from 2023.
  • KalVista Pharmaceuticals, Inc. annual Return On Assets for 2023 was -69%, a 74% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Return On Assets for 2022 was -40%, a 40% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -75% +10% +12% 01 Jul 2025 30 Sep 2025
Q2 2025 -85% -4% -5% 01 Apr 2025 30 Jun 2025
Q1 2025 -79% -2.2% -2.8% 01 Jan 2025 31 Mar 2025
Q4 2024 -77% -4.1% -5.7% 01 Nov 2024 31 Jan 2025
Q3 2024 -85% -27% -45% 01 Jul 2024 30 Sep 2024
Q2 2024 -81% -28% -52% 01 Apr 2024 30 Jun 2024
Q1 2024 -77% -26% -52% 01 Jan 2024 31 Mar 2024
Q4 2023 -73% -24% -51% 01 Nov 2023 31 Jan 2024
Q3 2023 -59% -11% -24% 01 Aug 2023 31 Oct 2023
Q2 2023 -54% -12% -28% 01 May 2023 31 Jul 2023
Q1 2023 -51% -15% -44% 01 Feb 2023 30 Apr 2023
Q4 2022 -48% -19% -65% 01 Nov 2022 31 Jan 2023
Q3 2022 -47% -19% -64% 01 Aug 2022 31 Oct 2022
Q2 2022 -42% -11% -36% 01 May 2022 31 Jul 2022
Q1 2022 -35% +1.8% +4.9% 01 Feb 2022 30 Apr 2022
Q4 2021 -29% +18% +39% 01 Nov 2021 31 Jan 2022
Q3 2021 -29% +13% +31% 01 Aug 2021 31 Oct 2021
Q2 2021 -31% +2.7% +8% 01 May 2021 31 Jul 2021
Q1 2021 -37% -9.9% -36% 01 Feb 2021 30 Apr 2021
Q4 2020 -48% -20% -74% 01 Nov 2020 31 Jan 2021
Q3 2020 -42% -20% -94% 01 Aug 2020 31 Oct 2020
Q2 2020 -33% -15% -79% 01 May 2020 31 Jul 2020
Q1 2020 -27% -8.1% -42% 01 Feb 2020 30 Apr 2020
Q4 2019 -27% -14% -100% 01 Nov 2019 31 Jan 2020
Q3 2019 -22% -3.7% -21% 01 Aug 2019 31 Oct 2019
Q2 2019 -19% +10% +36% 01 May 2019 31 Jul 2019
Q1 2019 -19% +14% +41% 01 Feb 2019 30 Apr 2019
Q4 2018 -14% +33% +71% 01 Nov 2018 31 Jan 2019
Q3 2018 -18% +45% +72% 01 Aug 2018 31 Oct 2018
Q2 2018 -29% +26% +48% 01 May 2018 31 Jul 2018
Q1 2018 -33% +26% +45% 01 Feb 2018 30 Apr 2018
Q4 2017 -46% +13% +22% 01 Nov 2017 31 Jan 2018
Q3 2017 -63% -14% -29% 01 Aug 2017 31 Oct 2017
Q2 2017 -55% -7.5% -16% 01 May 2017 31 Jul 2017
Q1 2017 -59% -15% -33% 01 Feb 2017 30 Apr 2017
Q4 2016 -59% -8.2% -16% 01 Nov 2016 31 Jan 2017
Q3 2016 -49% +18% +26% 01 Jul 2016 30 Sep 2016
Q2 2016 -48% 01 Apr 2016 30 Jun 2016
Q1 2016 -44% 01 Jan 2016 31 Mar 2016
Q4 2015 -51% 01 Oct 2015 31 Dec 2015
Q3 2015 -66% 01 Jul 2015 30 Sep 2015

KalVista Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -113% -44% -63% 01 May 2024 30 Apr 2025
2023 -69% -29% -74% 01 May 2023 30 Apr 2024
2022 -40% +26% +40% 01 May 2022 30 Apr 2023
2021 -66% -23% -53% 01 May 2021 30 Apr 2022
2020 -43% -16% -62% 01 May 2020 30 Apr 2021
2019 -27% +16% +38% 01 May 2019 30 Apr 2020
2018 -43% +0.21% +0.49% 01 May 2018 30 Apr 2019
2017 -43% -12% -37% 01 May 2017 30 Apr 2018
2016 -32% +20% +38% 01 May 2016 30 Apr 2017
2015 -51% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.